Posts tagged with: ABBOTT LABORATORIES

As You Sow (AYS), a shareholder activist group, was rebuffed last month in a move to curtail the use of Abbott Laboratories’ genetically modified organisms in its Similac Soy Isomil infant formulas. The defeat of the resolution marks the third year Abbott shareholders voted down an AYS effort to limit and/or label GMO ingredients by significant margins. This year’s resolution reportedly garnered only 3 percent of the shareholder vote.

Such nuisance resolutions fly in the face of the facts: GMOs have been found to be completely safe and, further, benefit the environment by increasing crop yields, thereby reducing the land area required for farming, as well as significantly reducing the need for pesticides. Try telling that to the AYS activists, whose 2015 Abbott resolution states:

 Shareholders request the Board of Directors publish within six months, at reasonable cost and excluding proprietary information, a report on genetically engineered ingredients contained in nutritional products sold by Abbott. This report should list Abbott product categories that contain GMOs and estimated portion of products in each category that contain GMOs, and discuss any actions management is taking to reduce or eliminate GMOs from its products, until and unless long-term studies show that the genetically engineered crops and associated farming practices are not harmful to the environment, the agriculture industry, or human or animal health.

“The full story is that GMOs are having a significant environmental impact and no agency is monitoring for health effects,” fretted Margaret Weber, corporate responsibility director at the Congregation of St. Basil of Toronto, an AYS member, one year ago. “In fact, monitoring for health impacts is nearly impossible because in the US, where the vast majority of GMOs are grown and consumed, there is no labeling.” (more…)

GM-corn-mIn Wednesday’s Wall Street Journal, Matthew Dalton reported that the European Union likely will approve a genetically modified organism for only the second time in the past 15 years. The EU is poised to grant E. I. du Pont de Nemours and Company permission to grow 1507, a DuPont-developed GMO corn.

DuPont first sought approval in 2001 for 1507 … After positive safety reviews and several decisions by the European Court of Justice criticizing the European Commission for delaying its decision, the commission is now close to approving the crop…

The crop ‘meets all EU regulatory requirements and should be approved for cultivation without further delay,’ DuPont said. (more…)

The Dow Chemical Co., along with E.I. Du Pont de Nemours, has come under fire from the Adrian Dominicans and the Sisters of Charity due to the companies’ production of genetically modified organisms.

No, the sisters aren’t mounting the barricades outside the two corporations to protest what they might term “Frankenfoods,” but they have submitted proxy shareholder resolutions to demand, among other things, the companies review and report by November 2013 on:

  1. Adequacy of plans for removing GE [genetically engineered] seed from the ecosystem should circumstances require;
  2. Possible impact on all Dow seed product integrity;
  3. Effectiveness of established risk management processes for different environments and agricultural systems.

According to the As You Sow 2013 Proxy Preview, Harrington Investments – described in the preview as “religious investors” – are pressing Monsanto to provide even more detailed reports by July 2013.

AYS, for its part, is taking on Abbott Laboratories with a resolution seeking the company remove all GMOs from the company’s Similac Isomil infant formula “with an interim step of [requiring] labeling” that Isomil includes GMOs. The resolution reads, in part, that Abbott: (more…)